| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b76244b2383ba8c0deff54adf963bf07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34e6d11143a14380857a18423bcbef28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3a57fa31a2c034d36d29c7e6b6d519a0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdb49514b1bb49f31e5005106d5fcfe1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate |
2009-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0df86bec815bc29057e83d160e678706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f2945d116efcee90bae67b82220e1e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_551b50b558f04293c4da23708e5b0b25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15f68c1e3fe07bb3c929a97f921d7859 |
| publicationDate |
2010-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010070589-A3 |
| titleOfInvention |
A novel dermaceutical cream made using sodium fusidate |
| abstract |
The present invention relates to primary and secondary bacterial skin infections and in particular it relates to the treatment of these infections using a Fusidic acid cream that has been made using Sodium fusidate as the starting Active Pharmaceutical Ingredient (API). The invention discloses a dermaceutical cream containing Fusidic acid which is formed in situ from Sodium Fusidate as the starting raw material, wherein Sodium Fusidate is converted into Fusidic acid under oxygen-free environment. The cream of the present invention has greater shelf-life stability and the finer particle size of the API than the conventional creams containing Fusidic acid. |
| priorityDate |
2008-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |